![Chris Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Chris Anderson currently works at DICE Therapeutics, Inc., as Secretary from 2023, Sigilon Therapeutics, Inc., as Secretary from 2023, and POINT Biopharma Global, Inc., as Secretary from 2023.
Actieve functies van Chris Anderson
| Bedrijven | Functie | Begin |
|---|---|---|
| DICE THER | Bedrijfssecretaris | 09-08-2023 |
| SIGILON THERAPEUTICS, INC. | Bedrijfssecretaris | 11-08-2023 |
| POIT BIOP | Directeur/Bestuurslid | 27-12-2023 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
Kies MarketScreener 
